11 June 2021: OIA response | Special Authority applications approved for emtricitabine with tenofovir disoproxil only

11 June 2021 

Dear [name and contact details withheld] 

REQUEST FOR INFORMATION 

Thank you for your request dated 25 May 2021 under the Official Information Act 1982 (OIA) for information relating to Special Authority applications for emtricitabine with tenofovir disoproxil only. You requested: 

The number of approved Special Authority applications (both initial and renewal applications) of emtricitabine with tenofovir disoproxil for the use of pre-exposure prophylaxis (PrEP), for any recent time frame... eg 2020. In particular:

  • at a national level
  • in the Wellington (CCDHB) region 

Please find the information requested provided within the tables below. Please note, these numbers represent the number of approved applications each month, not the number of people being dispensed the medicine each month. 

Additionally, we have provided a copy of the source data used to generate these tables. The source data includes a monthly breakdown by DHB of all initial and renewal applications approved in the calendar years 2019 and 2020. 

We trust that this information answers your queries. We are making our information more freely available, so we now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this. 

Yours sincerely 

Rachel Read
Manager, Policy and Government Services 

Table 1: National Special Authority applications approved for emtricitabine with tenofovir disoproxil only

Month

Initial

Renewal

Initial

Renewal

 

2019

2020

January

114

304

83

425

February

130

309

105

477

March

158

364

81

456

April

114

370

20

97

May

149

418

57

406

June

128

375

114

541

July

142

419

113

381

August

117

390

85

415

September

110

402

84

548

October

106

438

94

431

November

118

465

87

511

December

96

453

70

608

National total

1,482

4,707

993

5,296

Table 2: Capital and Coast DHB (CCDHB) Special Authority applications approved for emtricitabine with tenofovir disoproxil only

Month

Initial

Renewal

Initial

Renewal

 

2019

2020

January

12

42

14

42

February

17

49

14

60

March

23

42

13

51

April

14

51

3

10

May

13

67

4

38

June

11

48

15

62

July

18

50

17

57

August

18

54

12

56

September

14

54

11

70

October

12

51

14

55

November

17

76

6

54

December

11

64

14

75

CCDHB total

180

648

137

630